{"chunk_id": "medquad__chunk_30615", "source": "medquad", "text": "ns and hospital admissions.\n                \nUse in children. Studies in children with severe hemoglobin SS or S thalassemia showed that hydroxyurea reduced the number of vaso-occlusive crises and hospitalizations. A study of very young children (between the ages of 9 and 18 months) with hemoglobin SS or hemoglobin S thalassemia also showed that hydroxyurea decreased the number of episodes of pain and dactylitis.\n                \nWho Should Use Hydroxyurea?\n                \nSince hydroxyurea can"}